Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.

Annals of surgery - 1 Apr 2017

Luo Guopei, Liu Chen, Guo Meng, Cheng He, Lu Yu, Jin Kaizhou, Liu Liang, Long Jiang, Xu Jin, Lu Renquan, Ni Quanxing, Yu Xianjun

Abstract excerpt

OBJECTIVE: To examine potential biomarkers in Lewis negative patients with pancreatic cancer. BACKGROUND: Carbohydrate antigen 19-9 (CA19-9) is currently the most important and widely used biomarker in pancreatic cancer. However, approximately 5 to 10% of the population are Lewis negative individuals, and they are documented to have scarce or no CA19-9 secretion. Therefore, it is necessary to explore potential...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to CA-125 Antigen
Share to CA-19-9 Antigen

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Share to Databases, Factual

Share to Disease-Free Survival

Share to Kaplan-Meier Estimate

Share to Pancreatic Neoplasms

Share to Proportional Hazards Models

Share to ROC Curve

Source

Identifiers

PMID: 28267695
DOI: 10.1097/SLA.0000000000001741

Genes

AFP
FUT3

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Potential Biomarkers in Lewis Negative Patients With Pancreatic Cancer.PMID 28267695Read ↗

New observations on the utility of CA19-9 as a biomarker in Lewis negative patients with pancreatic cancer.Semantic proximity Read ↗

Optimize CA19-9 in detecting pancreatic cancer by Lewis and Secretor genotyping.Semantic proximity Read ↗

A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.Semantic proximity Read ↗

Gene Variants That Affect Levels of Circulating Tumor Markers Increase Identification of Patients With Pancreatic CancerSemantic proximity Read ↗

CA19-9-Low&Lewis (+) pancreatic cancer: A unique subtype.Semantic proximity Read ↗

Glycans Related to the CA19-9 Antigen Are Increased in Distinct Subsets of Pancreatic Cancers and Improve Diagnostic Accuracy Over CA19-9Semantic proximity Read ↗

Lewis Antigen Phenotype and Survival of Patients With Pancreatic Cancer.Semantic proximity Read ↗

Elevated serum levels of Dupan-2 in pancreatic cancer patients negative for Lewis blood group phenotype.Semantic proximity Read ↗

The relationship between Lewis/Secretor genotypes and serum carbohydrate antigen 19-9 levels in a Korean population.Semantic proximity Read ↗

The utility of a novel blood based biomarker in the diagnosis of pancreatic cancerSemantic proximity Read ↗

Cancer-associated tumour markers CA 19-9 and CA-50 in patients with pancreatic cancer with special reference to the Lewis blood cell status.Semantic proximity Read ↗

Evaluation of urinary CA19-9 levels in bladder cancer patients classified according to the combinations of Lewis and Secretor blood group genotypes.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.